The breast reconstruction market incorporates various technologies, with different surgical approaches being key determinants. Inframammary reconstruction involves incisions in the breast fold, providing direct access for implant placement. Peri-areolar reconstruction utilizes incisions around the areola. Trans-axillary reconstruction accesses the breast through an incision in the armpit, while transumbilical reconstruction involves incisions near the navel. Each technology caters to diverse patient preferences and clinical considerations, offering options for breast cancer survivors seeking reconstructive surgery tailored to their specific needs and desired outcomes.
Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/europe-breast-reconstruction-market
Data Bridge Market Research analyses that the Europe Breast Reconstruction Market, which was USD 567 million in 2021, is expected to reach USD 917.44 million by 2029 and is expected to undergo a CAGR of 6.2% during the forecast period of 2022-2029. The expansion of health insurance coverage for breast reconstruction procedures increases accessibility to these surgeries. It eliminates financial barriers and enables a broader range of breast cancer survivors to opt for reconstruction, enhancing their quality of life and recovery process.
Key Findings of the Study
Patient advocacy is expected to drive the market's growth rate
Patient advocacy groups play a vital role in the breast reconstruction market by providing support, information, and resources to individuals who have undergone mastectomies due to breast cancer. These groups empower patients to explore their options for breast reconstruction, ensuring they are well-informed about the available procedures, benefits, and the importance of their choices. By offering a sense of community, emotional support, and practical guidance, advocacy groups help individuals make informed decisions regarding their breast reconstruction, ultimately improving their quality of life.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
|
|
Market Players Covered
|
POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Material Co. Ltd (China), ALLERGAN (Ireland), Johnson & Johnson Private Limited (U.S), GC Aesthetics (U.K), Laboratories Arion (France), Sientra Inc. (U.S.), HANSBIOMED CO. LTD (South Korea), Sientra, Inc. (U.S), Deal Implant Incorporated (U.S), Integra LifeSciences (U.S), PMT Corporation (U.S), RTI Surgical (U.S), Establishment Labs S.A. (U.S), Silimed (Brazil)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Europe breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure, and end user.
- On the basis of product, the Europe breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix.
- On the basis of type, the Europe breast reconstruction market is segmented into unilateral, and bilateral.
- On the basis of shape, the Europe breast reconstruction market is segmented into round implants, and anatomical implants.
- On the basis of technology, the Europe breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical.
- On the basis of placement, the Europe breast reconstruction market is segmented into dual-plane insertion, subglandular insertion, and submuscular insertion.
- On the basis of procedure, the Europe breast reconstruction market is segmented into immediate procedures, delayed procedures, and revision procedures.
- On the basis of end user, the Europe breast reconstruction market is segmented into hospitals, cosmetology clinics, ambulatory surgical centers, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the Europe breast reconstruction market players in Europe breast reconstruction market are POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Material Co. Ltd (China), ALLERGAN (Ireland), Johnson & Johnson Private Limited (U.S), GC Aesthetics (U.K), Laboratories Arion (France), Sientra Inc. (U.S.).
Market Developments
- In 2022, Mentor Worldwide LLC, a subsidiary of Johnson & Johnson, received authorization from the US Food and Drug Administration for the MENTOR Memory Gel Enhanced breast implant. This approval signifies a new addition to Mentor's product portfolio, providing breast augmentation patients with an innovative and FDA-sanctioned option. The Memory Gel Enhanced implant reflects the company's commitment to delivering advanced breast reconstruction and enhancement solutions.
- In June 2022, Coll Plant launched a study involving large animals as part of its 3D bioprinted regenerative breast implant program. This initiative aims to cater to the specific requirements of breast reconstruction procedures. By leveraging advanced 3D bioprinting technology, Coll Plant seeks to develop innovative and regenerative breast implant solutions that could potentially transform the field of breast reconstruction, offering more natural and personalized options for patients.
- In May 2022, GC Aesthetics introduced FixNip NRI, an Innovative Areola Complex (NAC) reconstruction implant, addressing a widespread clinical need for women worldwide. This medical device offers a solution for breast cancer survivors and patients seeking nipple-areola complex reconstruction post-mastectomy. By providing a specialized and innovative implant, GC Aesthetics strives to enhance the quality of life and aesthetic outcomes for a significant number of women.
- In 2021, POLYTECH Health & Aesthetics received FDA approval for its textured breast implants, including macrotextured and polyurethane-coated varieties. This regulatory approval marked a significant milestone, allowing the company to offer these implants in the US market. The textured implants, renowned for their natural feel and aesthetic results, are now accessible to a broader range of patients seeking breast augmentation and reconstruction options, enhancing choices and outcomes in the field.
- In 2020, Sientra achieved pre-market approval from the US Food and Drug Administration for its OPUS-branded breast implant products. This regulatory milestone signified the company's commitment to delivering high-quality and safe breast implant options to the US market. With FDA approval, Sientra's OPUS implants became a trusted choice for breast augmentation and reconstruction, offering patients and surgeons a reliable and innovative solution for aesthetic and restorative procedures.
For more detailed information about the Europe breast reconstruction market report, click here – https://www.databridgemarketresearch.com/jp/reports/europe-breast-reconstruction-market
